Uehara Yoshinari, Urata Hidenori, Ideishi Munehito, Arakawa Kikuo, Saku Keijiro
Department of Internal Medicine, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.
Cardiovasc Res. 2002 Sep;55(4):870-6. doi: 10.1016/s0008-6363(02)00458-3.
The role of chymase (a mast cell-derived angiotensin II-forming serine proteinase) in aortic lipid deposition was investigated using an orally active, non-peptide chymase inhibitor, SUN-C8257.
Male golden Syrian hamsters, 8 weeks old, were fed with a standard rodent meal supplemented with or without 0.5% cholesterol and 10% coconut oil for 12 weeks. The hamsters fed high cholesterol diet were further separated into two groups treated with or without SUN-C8257 for 12 weeks. The aortic lipid deposition was visualized by Oil red O staining and planimetrically measured. Immunohistochemical staining for angiotensin II (Ang II) of the aortic root region was performed. Aortic Ang II-forming activity was measured using Ang I as a substrate. Plasma total-, low-density lipoprotein (LDL)-, high-density lipoprotein (HDL)-cholesterol and triglyceride were quantified by enzymatic methods. Plasma Ang I and Ang II were measured by radioimmunoassay.
After 12 weeks of high cholesterol diet, aortic chymase activity in the untreated group increased significantly and showed a positive correlation with plasma total- and LDL-cholesterol. This group of hamsters developed marked lipid deposits in the aortic intima. However, treatment with SUN-C8257 significantly suppressed aortic lipid deposition without changing body weight, blood pressure, plasma LDL-cholesterol and Ang II levels. The level of the adventitial Ang II-immunoreactivity was markedly inhibited in the group treated with SUN-C8257.
Our results suggest that arterial chymase may participate in the acceleration of lipid deposition in arterial walls exposed to high plasma cholesterol and that inhibition of arterial chymase may retard the progression of atherosclerosis.
使用口服活性非肽类糜酶抑制剂SUN - C8257研究糜酶(一种肥大细胞衍生的生成血管紧张素II的丝氨酸蛋白酶)在主动脉脂质沉积中的作用。
8周龄雄性金黄叙利亚仓鼠喂食添加或不添加0.5%胆固醇和10%椰子油的标准啮齿动物饲料12周。喂食高胆固醇饮食的仓鼠进一步分为两组,分别接受或不接受SUN - C8257治疗12周。通过油红O染色观察主动脉脂质沉积并进行平面测量。对主动脉根部区域进行血管紧张素II(Ang II)免疫组织化学染色。以血管紧张素I为底物测量主动脉生成Ang II的活性。通过酶法对血浆总胆固醇、低密度脂蛋白(LDL)胆固醇、高密度脂蛋白(HDL)胆固醇和甘油三酯进行定量。通过放射免疫测定法测量血浆血管紧张素I和血管紧张素II。
高胆固醇饮食12周后,未治疗组的主动脉糜酶活性显著增加,且与血浆总胆固醇和LDL胆固醇呈正相关。该组仓鼠在主动脉内膜出现明显的脂质沉积。然而,SUN - C8257治疗可显著抑制主动脉脂质沉积,而不改变体重、血压、血浆LDL胆固醇和Ang II水平。在接受SUN - C8257治疗的组中,外膜Ang II免疫反应性水平明显受到抑制。
我们的结果表明,动脉糜酶可能参与了高血浆胆固醇情况下动脉壁脂质沉积的加速过程,抑制动脉糜酶可能延缓动脉粥样硬化的进展。